Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-25-050918
Filing Date
2025-03-10
Accepted
2025-03-10 16:27:42
Documents
1
Effectiveness Date
2025-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 POS d894490ds8pos.htm S-8 POS 30783
  Complete submission text file 0001193125-25-050918.txt   31905
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-278250 | Film No.: 25724106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)